Log-in / Create Account  
Session Information
2008 BIO International Convention
Click here to go to the previous page
Investor Relations Practices Across Various Market-Cap Companies—Case Studies
Track : Public Relations/Investor Relations
Program Code: 1179
Date: Thursday, June 19, 2008
Time: 10:30 AM to 12:00 PM  EST
Location: 27AB
CHAIR :
Donna LaVoie, President & CEO , LaVoie Strategic Communications Group, Inc.
SPEAKER (S):
Michelle Dipp, Director of Corporate Development ., Sirtris Pharmaceuticals, Inc
Michael Partridge, Director, Corporate Communications , Vertex Pharmaceuticals, Inc.
Rebecca Peterson, Director, Corporate Communications , Alkermes, Inc.
Description
Managing private investor, shareholder and media expectations are significant challenges for investor relations and business development professionals. A panel of IR and business development professionals from different market-cap companies (including Vertex, Alkermes and Sirtris) will share their experiences and best practices in biotech at this session.

Objective1:Explore 10 critical investor relations (IR) topics.

Objective2:Explain the variations in tactics used by IR and business development professionals to communicate with their constituencies.

Objective3:Share the real-world experiences of each panelist to transfer knowledge to other biotechnology companies around the globe.

Streaming Audio with
PowerPoint Slides
(Code: 1179)
  
This session is a part of:
2008 BIO International Convention Complete Session Set
Public Relations/Investor Relations Track